Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma cruzi | 13 | 2023 | 149 | 1.380 |
Why?
|
| Chagas Disease | 7 | 2023 | 98 | 0.810 |
Why?
|
| Proteome | 4 | 2024 | 144 | 0.700 |
Why?
|
| Protozoan Proteins | 7 | 2021 | 182 | 0.580 |
Why?
|
| Thrombospondin 1 | 3 | 2022 | 23 | 0.490 |
Why?
|
| RNA, Small Interfering | 4 | 2021 | 409 | 0.480 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 1502 | 0.480 |
Why?
|
| Proteomics | 6 | 2024 | 325 | 0.460 |
Why?
|
| Semen | 2 | 2021 | 51 | 0.370 |
Why?
|
| Trypanosoma brucei brucei | 2 | 2021 | 83 | 0.340 |
Why?
|
| Exosomes | 3 | 2019 | 101 | 0.320 |
Why?
|
| Porphyromonas gingivalis | 3 | 2024 | 32 | 0.300 |
Why?
|
| Cocaine | 2 | 2021 | 232 | 0.270 |
Why?
|
| Benzo(a)pyrene | 2 | 2021 | 126 | 0.270 |
Why?
|
| Monocytes | 2 | 2021 | 257 | 0.250 |
Why?
|
| Humans | 32 | 2024 | 37093 | 0.250 |
Why?
|
| Epithelial Cells | 3 | 2018 | 384 | 0.240 |
Why?
|
| Streptococcus | 1 | 2024 | 16 | 0.240 |
Why?
|
| Dental Plaque | 1 | 2024 | 14 | 0.240 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2022 | 59 | 0.230 |
Why?
|
| Periodontitis | 1 | 2024 | 53 | 0.220 |
Why?
|
| HIV Infections | 4 | 2021 | 2303 | 0.220 |
Why?
|
| Protein Folding | 1 | 2024 | 127 | 0.220 |
Why?
|
| Protein Conformation | 1 | 2024 | 389 | 0.210 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 8 | 0.210 |
Why?
|
| Gastritis | 1 | 2022 | 11 | 0.210 |
Why?
|
| Pancreatitis | 1 | 2022 | 17 | 0.210 |
Why?
|
| Hypercalcemia | 1 | 2022 | 13 | 0.210 |
Why?
|
| beta Catenin | 1 | 2022 | 48 | 0.200 |
Why?
|
| HIV-1 | 2 | 2019 | 706 | 0.200 |
Why?
|
| Chemotaxis | 1 | 2021 | 60 | 0.200 |
Why?
|
| Metformin | 1 | 2022 | 65 | 0.200 |
Why?
|
| Trypanosomiasis, African | 1 | 2021 | 23 | 0.200 |
Why?
|
| Prostatic Neoplasms | 3 | 2022 | 935 | 0.200 |
Why?
|
| Gene Regulatory Networks | 4 | 2021 | 120 | 0.190 |
Why?
|
| Endothelial Cells | 2 | 2022 | 308 | 0.190 |
Why?
|
| Myoblasts | 1 | 2020 | 27 | 0.180 |
Why?
|
| Obstetric Labor, Premature | 2 | 2010 | 13 | 0.180 |
Why?
|
| Cell Cycle | 1 | 2021 | 326 | 0.180 |
Why?
|
| Blood | 1 | 2019 | 37 | 0.180 |
Why?
|
| Hepatitis C, Chronic | 1 | 2019 | 39 | 0.170 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 46 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 186 | 0.160 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2019 | 121 | 0.160 |
Why?
|
| RNA, Messenger | 5 | 2022 | 1207 | 0.160 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 166 | 0.160 |
Why?
|
| Myocardium | 1 | 2020 | 235 | 0.160 |
Why?
|
| Homeostasis | 1 | 2019 | 188 | 0.150 |
Why?
|
| Colon | 1 | 2018 | 103 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2018 | 163 | 0.150 |
Why?
|
| Cell Nucleus | 2 | 2016 | 366 | 0.150 |
Why?
|
| Mouth | 1 | 2017 | 45 | 0.150 |
Why?
|
| Periodontal Diseases | 1 | 2017 | 49 | 0.140 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2016 | 11 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2021 | 426 | 0.140 |
Why?
|
| Female | 11 | 2024 | 20969 | 0.140 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2016 | 8 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 626 | 0.140 |
Why?
|
| Fimbriae, Bacterial | 1 | 2014 | 23 | 0.130 |
Why?
|
| Transport Vesicles | 1 | 2014 | 21 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2017 | 316 | 0.120 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 1 | 2014 | 8 | 0.120 |
Why?
|
| Virus Integration | 1 | 2015 | 58 | 0.120 |
Why?
|
| Adenoviridae | 1 | 2014 | 62 | 0.120 |
Why?
|
| Mice | 8 | 2022 | 5913 | 0.120 |
Why?
|
| Animals | 12 | 2022 | 15081 | 0.120 |
Why?
|
| Phosphorus-Oxygen Lyases | 1 | 2014 | 6 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2014 | 158 | 0.120 |
Why?
|
| Capsid Proteins | 1 | 2014 | 67 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 807 | 0.120 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2014 | 48 | 0.120 |
Why?
|
| alpha-Defensins | 1 | 2013 | 17 | 0.110 |
Why?
|
| Cell Membrane | 2 | 2013 | 381 | 0.110 |
Why?
|
| Flagella | 1 | 2013 | 29 | 0.110 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 2231 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 259 | 0.110 |
Why?
|
| Locomotion | 1 | 2013 | 97 | 0.110 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 126 | 0.110 |
Why?
|
| Calreticulin | 1 | 2012 | 7 | 0.110 |
Why?
|
| Cell Adhesion | 2 | 2012 | 212 | 0.100 |
Why?
|
| Models, Biological | 3 | 2018 | 677 | 0.100 |
Why?
|
| Cytidine Deaminase | 1 | 2011 | 34 | 0.100 |
Why?
|
| Fetus | 1 | 2012 | 105 | 0.100 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 664 | 0.090 |
Why?
|
| Heart | 2 | 2023 | 180 | 0.090 |
Why?
|
| Acinetobacter Infections | 1 | 2010 | 22 | 0.090 |
Why?
|
| Prostate | 1 | 2011 | 154 | 0.090 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2010 | 30 | 0.090 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 325 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 62 | 0.090 |
Why?
|
| Cross Infection | 1 | 2010 | 38 | 0.090 |
Why?
|
| Acinetobacter baumannii | 1 | 2010 | 33 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2021 | 928 | 0.090 |
Why?
|
| Coronary Vessels | 1 | 2010 | 85 | 0.090 |
Why?
|
| Male | 8 | 2022 | 20025 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2010 | 86 | 0.080 |
Why?
|
| RNA Interference | 2 | 2010 | 243 | 0.080 |
Why?
|
| Leukocytes | 1 | 2009 | 72 | 0.080 |
Why?
|
| Rats | 4 | 2022 | 3483 | 0.080 |
Why?
|
| Young Adult | 4 | 2021 | 4268 | 0.080 |
Why?
|
| Neoplasms | 2 | 2021 | 1103 | 0.080 |
Why?
|
| Myoblasts, Cardiac | 1 | 2006 | 4 | 0.070 |
Why?
|
| Mitochondria | 2 | 2021 | 487 | 0.070 |
Why?
|
| Casein Kinase II | 1 | 2006 | 15 | 0.070 |
Why?
|
| Neoplasm Proteins | 2 | 2022 | 213 | 0.070 |
Why?
|
| Viral Load | 2 | 2019 | 312 | 0.070 |
Why?
|
| Laminin | 1 | 2006 | 61 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2006 | 151 | 0.060 |
Why?
|
| Fimbriae Proteins | 2 | 2014 | 21 | 0.060 |
Why?
|
| Neuraminidase | 2 | 2006 | 9 | 0.060 |
Why?
|
| Cell Line | 2 | 2021 | 1354 | 0.060 |
Why?
|
| Nitrogen | 1 | 2005 | 71 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2020 | 1908 | 0.060 |
Why?
|
| Middle Aged | 4 | 2021 | 10129 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2005 | 206 | 0.060 |
Why?
|
| Gene Expression | 3 | 2011 | 674 | 0.060 |
Why?
|
| Disease Progression | 2 | 2016 | 601 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1015 | 0.060 |
Why?
|
| Castration | 1 | 2022 | 34 | 0.050 |
Why?
|
| Adult | 4 | 2021 | 11712 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 1518 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 661 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2006 | 517 | 0.050 |
Why?
|
| Aged | 3 | 2021 | 6741 | 0.050 |
Why?
|
| Androgens | 1 | 2022 | 89 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 31 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 57 | 0.050 |
Why?
|
| Acute Disease | 1 | 2022 | 147 | 0.050 |
Why?
|
| DNA, Kinetoplast | 1 | 2021 | 3 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 126 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 59 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 306 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2023 | 272 | 0.050 |
Why?
|
| Pregnancy | 3 | 2012 | 1549 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 197 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 2379 | 0.050 |
Why?
|
| Cell Movement | 2 | 2016 | 571 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 230 | 0.050 |
Why?
|
| Communicable Diseases | 1 | 2021 | 45 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1039 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 51 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 213 | 0.050 |
Why?
|
| Tennessee | 1 | 2019 | 70 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 5363 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 2026 | 0.040 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 14 | 0.040 |
Why?
|
| Base Sequence | 1 | 2021 | 997 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 61 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 623 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2020 | 174 | 0.040 |
Why?
|
| Calcium | 1 | 2022 | 480 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2022 | 933 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 190 | 0.040 |
Why?
|
| Glycoproteins | 1 | 1999 | 106 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 628 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2019 | 125 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 441 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 1609 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1999 | 120 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2019 | 157 | 0.040 |
Why?
|
| DNA Damage | 1 | 2021 | 352 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 229 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 301 | 0.040 |
Why?
|
| Risk Factors | 2 | 2019 | 3562 | 0.040 |
Why?
|
| Gastrointestinal Motility | 1 | 2017 | 18 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 42 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 539 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 1180 | 0.030 |
Why?
|
| Saliva | 1 | 2017 | 107 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 1568 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 90 | 0.030 |
Why?
|
| Macrophages | 1 | 1999 | 439 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 115 | 0.030 |
Why?
|
| Vesiculovirus | 1 | 2015 | 5 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Biofilms | 1 | 2017 | 168 | 0.030 |
Why?
|
| Proviruses | 1 | 2015 | 29 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1198 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 159 | 0.030 |
Why?
|
| Virion | 1 | 2015 | 69 | 0.030 |
Why?
|
| Ligands | 2 | 2010 | 349 | 0.030 |
Why?
|
| Cocaine-Related Disorders | 1 | 2015 | 85 | 0.030 |
Why?
|
| Endocytosis | 1 | 2015 | 113 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2014 | 37 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 236 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 302 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 35 | 0.030 |
Why?
|
| Virulence | 1 | 2014 | 223 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 938 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2015 | 304 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 168 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 149 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 502 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2010 | 513 | 0.030 |
Why?
|
| Plasminogen | 1 | 2012 | 10 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 623 | 0.030 |
Why?
|
| Life Cycle Stages | 1 | 2012 | 29 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 131 | 0.030 |
Why?
|
| Systole | 1 | 2012 | 61 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2012 | 105 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 89 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 602 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 67 | 0.030 |
Why?
|
| Computational Biology | 1 | 2014 | 293 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 201 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 251 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 77 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2010 | 39 | 0.020 |
Why?
|
| Uterus | 1 | 2010 | 55 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 39 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 260 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 162 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 186 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 434 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 71 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 435 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 201 | 0.020 |
Why?
|
| Virus Replication | 1 | 2011 | 278 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 859 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 455 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 1095 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 972 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2009 | 66 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 146 | 0.020 |
Why?
|
| Urban Population | 1 | 2010 | 333 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 400 | 0.020 |
Why?
|
| Premature Birth | 1 | 2009 | 75 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 562 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 182 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 169 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 578 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 352 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 441 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2006 | 167 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2006 | 212 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2006 | 72 | 0.020 |
Why?
|
| Prions | 1 | 2005 | 25 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2006 | 113 | 0.020 |
Why?
|
| Mathematics | 1 | 2005 | 48 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 88 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 111 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 118 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 2721 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2005 | 249 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2005 | 681 | 0.010 |
Why?
|
| Maleimides | 1 | 1999 | 13 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 52 | 0.010 |
Why?
|
| Cytosol | 1 | 1999 | 93 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 444 | 0.010 |
Why?
|
| Indoles | 1 | 1999 | 158 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 290 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 433 | 0.010 |
Why?
|